Tag: GMP violations

How NMPA GMP Helps Manage Risk in Pharmaceutical Manufacturing

Posted on By digi

How NMPA GMP Helps Manage Risk in Pharmaceutical Manufacturing How NMPA GMP Helps Manage Risk in Pharmaceutical Manufacturing Introduction to NMPA GMP and Risk Management The pharmaceutical industry is one of the most heavily regulated sectors globally due to the potential risks associated with drug manufacturing, distribution, and usage. Ensuring the safety, efficacy, and quality…

Read More “How NMPA GMP Helps Manage Risk in Pharmaceutical Manufacturing” »

NMPA GMP Guidelines

Best Practices for Ensuring EMA GMP Compliance in Pharmaceutical R&D

Posted on By digi

Best Practices for Ensuring EMA GMP Compliance in Pharmaceutical R&D Ensuring EMA GMP Compliance in Pharmaceutical Research and Development Introduction to EMA GMP in Pharmaceutical R&D Pharmaceutical research and development (R&D) is the foundation of creating innovative drugs that improve patient outcomes. While R&D primarily focuses on discovery and preclinical studies, compliance with the European…

Read More “Best Practices for Ensuring EMA GMP Compliance in Pharmaceutical R&D” »

EMA GMP Guidelines

How to Use WHO GMP Guidelines to Improve Manufacturing Efficiency

Posted on By digi

How to Use WHO GMP Guidelines to Improve Manufacturing Efficiency Enhancing Manufacturing Efficiency with WHO GMP Guidelines Introduction to Manufacturing Efficiency and WHO GMP Manufacturing efficiency is a cornerstone of the pharmaceutical industry, ensuring the consistent production of high-quality medicines while optimizing resources and minimizing costs. The World Health Organization (WHO)’s Good Manufacturing Practices (GMP))…

Read More “How to Use WHO GMP Guidelines to Improve Manufacturing Efficiency” »

WHO GMP Guidelines

MHRA GMP Guidelines for Clinical Manufacturing: What Pharma Companies Need to Know

Posted on By digi

MHRA GMP Guidelines for Clinical Manufacturing: What Pharma Companies Need to Know Understanding MHRA GMP Guidelines for Clinical Manufacturing Introduction to Clinical Manufacturing and MHRA GMP Clinical manufacturing refers to the production of investigational medicinal products (IMPs) used in clinical trials. These products are critical for evaluating the safety, efficacy, and quality of new drugs…

Read More “MHRA GMP Guidelines for Clinical Manufacturing: What Pharma Companies Need to Know” »

MHRA GMP Guidelines

The Role of TGA GMP in Quality Assurance and Control

Posted on By digi

The Role of TGA GMP in Quality Assurance and Control How TGA GMP Ensures Excellence in Quality Assurance and Control Introduction to TGA GMP and Quality Assurance The Therapeutic Goods Administration (TGA) enforces stringent Good Manufacturing Practices (GMP) to regulate the production and distribution of pharmaceutical products in Australia. A cornerstone of TGA GMP compliance…

Read More “The Role of TGA GMP in Quality Assurance and Control” »

TGA GMP Guidelines

The Role of Documentation in Achieving ANVISA GMP Compliance

Posted on By digi

The Role of Documentation in Achieving ANVISA GMP Compliance The Role of Documentation in Achieving ANVISA GMP Compliance Introduction to ANVISA GMP and the Importance of Documentation The National Health Surveillance Agency (ANVISA) plays a critical role in ensuring the safety, quality, and efficacy of pharmaceutical products in Brazil. One of the primary regulatory frameworks…

Read More “The Role of Documentation in Achieving ANVISA GMP Compliance” »

GMP in Latin America (ANVISA, COFEPRIS)

How PMDA GMP Ensures the Safety of Injectable Drugs in Japan

Posted on By digi

How PMDA GMP Ensures the Safety of Injectable Drugs in Japan How PMDA GMP Ensures the Safety of Injectable Drugs in Japan Introduction to Injectable Drugs and PMDA GMP Injectable drugs are a critical category of pharmaceutical products used in the treatment of a wide range of medical conditions, from chronic illnesses to acute emergencies….

Read More “How PMDA GMP Ensures the Safety of Injectable Drugs in Japan” »

PMDA GMP Guidelines

How NMPA GMP Affects the Global Supply Chain for Pharmaceuticals

Posted on By digi

How NMPA GMP Affects the Global Supply Chain for Pharmaceuticals How NMPA GMP Affects the Global Supply Chain for Pharmaceuticals Introduction to NMPA GMP and the Global Pharmaceutical Supply Chain The pharmaceutical industry operates in a globalized market, where drugs and other medical products are manufactured, tested, and distributed across multiple countries. As such, ensuring…

Read More “How NMPA GMP Affects the Global Supply Chain for Pharmaceuticals” »

NMPA GMP Guidelines

How WHO GMP Guidelines Promote Sustainability in Drug Manufacturing

Posted on By digi

How WHO GMP Guidelines Promote Sustainability in Drug Manufacturing Integrating Sustainability into Pharmaceutical Manufacturing with WHO GMP Guidelines Introduction to Sustainability in Drug Manufacturing Sustainability is becoming a critical focus in pharmaceutical manufacturing as industries worldwide strive to minimize their environmental impact while maintaining quality and efficiency. The World Health Organization (WHO)’s Good Manufacturing Practices…

Read More “How WHO GMP Guidelines Promote Sustainability in Drug Manufacturing” »

WHO GMP Guidelines

How Schedule M (Revised) GMP Enhances Risk Management in Pharma Manufacturing

Posted on By digi

How Schedule M (Revised) GMP Enhances Risk Management in Pharma Manufacturing Strengthening Risk Management in Pharmaceutical Manufacturing with Schedule M (Revised) GMP Introduction to Risk Management in Pharmaceutical Manufacturing In pharmaceutical manufacturing, managing risks is essential to ensure product quality, patient safety, and regulatory compliance. Risks can arise at various stages, from raw material procurement…

Read More “How Schedule M (Revised) GMP Enhances Risk Management in Pharma Manufacturing” »

SCHEDULE - M - Revised